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ABSTRACT 
DEVELOPMENT OF 3-D LIVER MODEL FOR  
DRUG SCREENING APPLICATIONS 
by 
Divya Rajendran 
The need for a an in vitro drug screening system that mimics the structural 
organization of natural liver for multi-functionality and maintenance of hepatocytes has 
become vital in the drug development process. The objective of this study was to 
engineer a three-dimensional (3-D) liver model using chitosan-based nanofiber scaffolds 
and co-culture system (adult rat hepatocytes and 3T3-J2 fibroblasts) to mimic the natural 
liver and to justify its application for in vitro drug screening. Chitosan nanofiber scaffolds 
were fabricated by electrospinning technique. In order to promote cell adhesion on the 
chitosan scaffolds, the scaffolds were coated with a cell adhesion molecule, fibronectin, 
by adsorption. The effects of mono-culture and co-culture systems on the proliferation 
and functional activities of hepatocytes were investigated. Lastly, the utilization of the 
optimized 3-D model for drug screening was tested. The results showed that 3-D in vitro 
liver model in co-culture maintained hepatic morphology and shows suitable liver 
function such as albumin secretion for a prolonged period. The model showed acceptable 
cytochrome P450 enzyme activity which plays a key role in drug metabolism. 
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CHAPTER 1  
INTRODUCTION 
1.1 Objective 
Drug biotransformation is one of the most important factors which is used to identify the 
overall therapeutic and toxicity profile of a new therapeutic agent. The drug discovery 
and development process is long and often hindered by unanticipated problems. It 
involves a series of investigational phases, starting by demonstrating the efficacy in 
experimental cell and animal models, followed by a concluding demonstration of safety 
and efficacy in humans. Drugs can fail at any point in this investigating timeline. 
Therefore, the study of various aspects of metabolism and toxicity of xenobiotics, 
especially those of new drugs and new chemical entities with the aid of the use of in vitro 
and in vivo systems, becomes an essential part of drug development and discovery 
process [1]. There may be various reasons for failure however, the most common is often 
due to unacceptable toxicity in one or more animal species or in clinical trials, which 
leads to terrible losses in cost and time [2, 3].  This can be avoided if hepatotoxicity is 
identified earlier in the development process namely, the pre-clinical stage. However, 
since only a small quantity of drug is available for testing in the early stages, the only 
possible approach is in vitro testing [4]. Therefore, it is vital to mimic the structural 
organization of natural liver for multi-functionality and maintenance of hepatocytes in 
order to create a human-relevant in vitro drug screening system. 
The objective of this project was to develop a 3-D liver model utilizing pure 
chitosan nanofibers and a co-culture system which would mimic the multi-functionality 
of natural liver that could be used for in vitro drug screening applications. The proposed 
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model consists of a layer of chitosan nanofiber scaffold coated with fibronectin which 
was followed by seeding of fibroblast and primary rat hepatocyte co-culture system. The 
chitosan nanofiber provides a three dimensional porous structural construct to enhance 
cell migration, attachment and proliferation. The fibronectin coating further enhances 
hepatocytes adhesion and spreading within the three dimensional construct. Lastly, the 
co-culture systems aim is to prolong and maintain the hepatic function and morphology 
of the hepatocytes. 
Figure 1.1  Schematic representation of the proposed 3-D Liver Model. 
The overall objective can be divided into four specific aims as follows: 
1. Fabrication of pure chitosan nanofibers 
2. Optimization of microenvironment of the scaffold 
3. Characterization of the proposed cell model 
4. To test the proposed models application for drug screening 
1.2 Structure and Function of Liver  
The liver is a highly metabolic, complex array of vasculature, endothelial cells and 
parenchymal cells that performs many functions in the body. The liver carries out a large 
number of functions that detoxifies endogenous (bilirubin and ammonia) and exogenous 
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(drugs and environmental compounds). It also carries out metabolic activities such as 
cytochrome P - 450, glycogen storage, urea production and release of proteins (albumin 
and clotting factors), carbohydrates, lipids and metabolic wastes [5].  
The hepatocytes constitute 70% of the liver mass and are the primary exhibitors 
of hepatic functions. The non-parenchymal cells such as stellate cells, kupffer cells, 
epithelial cells, sinusoidal epithelial cells, biliary epithelial cells and fibroblasts interact 
with hepatocytes to modulate their various functions [5, 6]. 
The cells in the liver are arranged in a highly intricate manner to allow optimal 
communication and attachment between the cells. Communications between the cells are 
vital to allow them to differentiate, grow, function, and apoptosis. This communication is 
carried out through cellular gap junctions, chemical signals and extra cellular matrix 
(ECM) [5, 7].  
Hepatocytes are attached to the basal membrane composed of laminin and type IV 
collagen. The hepatic plates are separated by the sinusoidal spaces which in turn are lined 
with endothelial cells. They are connected to other cells through homotypic or 
heterotypic cellular junctions, altered by the cell adhesion molecules binding to receptors 
and surrounded by an ECM which consists of fibronectin, type I and type II collagen [1, 
5, 8]. 
Extracellular matrix proteins are well distributed in varying amounts throughout 
the normal liver. ECM proteins in the liver include collagen (mainly type I and minor 
quantities of III, IV, V and VI), fibronectin, vitronectin, tenascin, elastin, proteoglycans, 
ECM-bound growth factors and small amounts of laminin [9]. Laminin and type IV 
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collagen dominate the periportal areas whereas fibronectin and type I collagen in the 
perivenous areas [10].  
 Thus, a very well defined microarchitecture, cell-cell, cell-soluble factor and cell-
matrix interactions allow the liver to carry out its diverse functions. 
 
 
 
 
 
 
 
 
 
 
Figure 1.2  Structure of liver [11]. 
1.3 Drug Metabolism 
Drug metabolism is vital for pharmacology for many reasons. Firstly, the toxin level in 
the blood is controlled by the metabolism of drugs and therefore influences it therapeutic 
and/or possible toxic effects. Second, some drugs require biotransformation into active 
metabolites for therapeutic applications. Third, it may generate highly reactive 
metabolites which after covalent binding to either proteins or nucleic acids, may generate 
serious side effects and pathologies. Lastly, drugs may modify the response of the 
organism to other compounds which are biotransformed by these enzyme systems[12]. 
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Drug metabolism is generally divided in to two phases. Phase I or 
functionalization reactions and Phase II or conjugative reactions. The biotransformation 
pathway is usually determined by either Phase I or II or both [1, 12-14]. Major part of 
biotransformation occurs through Phase I reactions mainly through oxidation performed 
by the microsomal mixed-function oxidase system also known as the cytochrome P450 
(CYP 450) family of enzymes and in small percentage by other groups such as flavin-
containing monoxygenase. In Phase II reactions involves a wide range of enzymes along 
with an ‘activated’ co-factor or a substrate derivative resulting in a water soluble final 
product which is excreted through bile or urine [13, 14].  
 
Table 1.1 Classifications of Chemical Reactions for Phase I and Phase II of Drug 
Metabolism [14]  
 
Phase I Phase II 
Oxidation Glucuronidation/glucosidation 
 
Reduction 
 
Sulfation 
 
Hydrolysis Methylation 
 
Hydration Acetylation 
 
Dethioacetylation Amino acid conjugation 
 
Isomerisation Glutathione conjugation 
Fatty Acid conjugation 
Condensation 
 
6 
 
1.4 Need for In Vitro System for Drug Metabolism 
The main aim of drug metabolism studies is to determine what happens in humans due to 
the action of the drug and/or its metabolites. These studies are also important to 
understand the pathway of metabolism of compounds in man, to determine the efficacy, 
duration of action and toxicity of the drug. Liver is the principal target organ for the 
obnoxious effects of xenobiotics, in addition to being the main organ responsible for drug 
metabolism. Metabolism also occurs in other organs such as kidney, lungs, intestine, skin 
and brain to a lesser extent[2, 13]. 
It has also been found that only 43% of the results obtained from animal testing 
are congruent with human clinical trial results. Russel and Burch, proposed a 3R 
principle – Replacement, Reduction and Refinement of humane handling of laboratory 
animals. An in vitro model will replace animal models in drug discovery and toxicity 
testing, in addition to providing more reliable data[15]. 
In order to evaluate hepatic drug intake and metabolism, microsomal cytochrome 
P450 induction, drug interactions, hepatotoxicity and cholestasis to improve drug 
development and discovery process, it is vital to maintain a well-differentiated hepatocyte 
culture for prolonged periods of time with intact Phase I and Phase II biotransformation 
capacities [1]. However, availability of healthy liver samples are limited by ethical 
constraints and the difficulty of finding homogeneous group of subjects to perform 
studies. Studies cannot be conducted on humans due to ethical and practical constraints. 
It is ethically not acceptable to take a liver sample from a healthy volunteer considering 
the risks of the procedure. Hence, the samples that are generally available are more or 
less diseased tissues, which make interpretation of data and extrapolation to the normal 
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human difficult [14]. The development of a successful in vitro liver model, will minimize 
the use of laboratory animal and reduces post market withdrawal of drugs[13].  
However, the conventionally available cellular assays are two dimensional and 
thus not able to predict the effects of new drugs on organisms. This is due to the isolation 
of cells from their native microenvironment. The primary hepatocytes cultured on 2-D 
become undifferentiated after a few passages and lose their liver-specific functions such 
as their ability to synthesis drug metabolizing enzymes[15]. 
1.5 Ideal In Vitro Model 
An ideal in vitro  drug screening model must maintain well-differentiated hepatocyte 
culture for prolonged periods of time with intact Phase I and Phase II biotransformation 
capacities, it must mimic the natural liver functions and architecture, it must be able to 
evaluate hepatic drug intake and metabolism, microsomal cytochrome P450 induction, 
drug interactions, hepatotoxicity and cholestasis. This would minimize the use of 
laboratory animal. It would also reduce the possibility of post market withdrawal of drugs 
which usually occurs due to the different ways that each individual reacts to a drug. 
1.6 Current In Vitro Models
It has already been well established that a successful drug must have acceptable 
absorption, distribution, metabolism and excretion (ADME) properties [15]. Numerous 
models have been proposed for in vitro testing for drug development.  These methods are 
useful to determine metabolic stability, large-scale metabolite generation, metabolite 
generation for bioanalytical assay development, metabolite profile comparison, and 
assessment of species differences in metabolism. It also helps in the rational selection of 
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animal species for toxicological studies and also provides data regarding the prediction of 
pharmacokinetic variability within the patient population and drug-drug interactions 
during clinical trials [1, 12, 15]. Current models that are available for drug developments 
are recombinant enzymes such as supersomes and microsomes; subcellular fractions, cell 
lines, hepatocytes and liver slices. Figure 1.3 provides a comparison of the different in 
vitro and in vivo models on their complexity, the ease of application, ethical standards 
and the resemblance of the models to the natural liver. Table 1.2 provides a list of current 
in vitro techniques available with a list of their advantages and disadvantages. 
 
Figure 1.3  In vitro and in vivo models that are available for drug screening in order of in 
vivo resemblance [16]. 
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Table 1.2  Summary of Advantages and Disadvantages of In Vitro Drug Screening 
Techniques [2, 13, 16] 
METHOD ADVANTAGE DISADVANTAGE 
Supersomes  Can be used for DDI studies 
 Maybe used to study the influences 
of different polymorphisms 
 Different genotypes of CYP are 
commercially available 
 The active sites of supersomes 
are shielded behind a 
hydrophobic barrier which leads 
to  latency of glucuronidations 
Microsomes  Low cost 
 Simplicity of use 
 Well established method,  
 Interindividual variations can be 
studied 
 Cannot be used for quantitative 
measurements 
 Incomplete representation of in 
vivo situations 
 Only CYP and UGT enzymes 
Cytosol 
fractions 
 Biotransformation capacity of 3 
distinct enzymes can be studied 
separately or in combination. 
 Only soluble phase II enzymes 
are present 
S9 fractions  Contain both phase I and phase II 
activity 
 Overall enzyme activity is low 
Liver cell lines  Easier to culture  
 Stable enzyme concentration 
 Absence or low expression of 
important phase I and phase II 
drug metabolizing enzymes 
 Difficult to detect metabolites 
 Difficult to investigate to 
individual CYPS or other 
enzymes due to low expression 
levels 
Transgenic cell 
lines 
 Easy to culture 
 High expression of UGT and CYP 
isozymes 
 Commercially available 
 Only one or a few isoenzymes 
are expressed 
 Expensive 
Hepatocytes  Strong resemblance to in vivo 
human liver 
 Well established and characterized 
 Study of mediators and enzyme 
inducers 
 Drug transporters still viable  
 Cryopreservation is possible 
 
 Isolation is difficult and time 
consuming 
 Cell damage due to isolation 
 Only preselected cells can be 
studied 
 Difficult to maintain in vitro 
culture 
 Prolonged culture conditions 
leads to complicated data 
interpretation 
 Cellular interactions more 
difficult to study 
 Interindividual variations 
Liver Slices  Best representation of in vivo 
situation 
 Bile can be collected and analyzed 
 3D architecture 
 All cell types available 
 Delicate model difficult to 
handle 
 Limited experimental viable 
periods 
 Poor reproducibility 
 No human liver available 
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1.7 Hepatocytes 
Primary adult hepatocytes have a very high proliferative rate in vivo; however, efforts to 
mimic the same property in vitro have not been successful. Primary hepatocytes generally 
have low mitotic activity in vitro. Another major drawback of hepatocytes is the low 
availability of mature, functional cells. Several culture systems have been developed over 
the years to maintain hepatocyte-specific functions such as the collagen sandwich 
configuration [17], spheroid culture [18], matrigel culture [19] and 
dimethylsulfoxide(DMSO)- supplemented culture medium[20]. However, these models 
do not have the capacity to exhibit any significant rate of replication and the hepatocytes 
grown are not able to respond fully to growth factor signals. Researchers have also been 
exploring alternate sources of cells such as hepatic progenitors, embryonic stem cells, 
immortalized hepatocytes or liver-tumor derived cell lines. But, this area has had limited 
success [18, 21]. 
1.8 Co-culture Systems 
Complex relationships between cellular and non-cellular elements in the liver, modulates 
hepatocyte functions. The maintenance of hepatocyte phenotype is dependent on 
microenvironmental signals such as paracrine interactions (cell-cell), physical-chemical 
factors (oxygen tension, metabolites), mechanical stimuli (blood flow) and cell-ECM 
interactions.  The three main methods by which long term hepatocyte functions are 
maintained in vitro are : (1) using hormonally defined media containing soluble factors; 
(2) restoring cell-cell contacts by culturing primary hepatocytes with other cells (either 
non-parenchymal liver cells or non-hepatic cells) and (3) re-establishing cell-ECM 
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contacts by culturing primary hepatocytes with individual ECM components or complex 
ECM substrata[22].  
This research will be concentrating on the second approach i.e. restoring cell-cell 
contact by culturing primary hepatocytes with other cells. Co-cultures of two cell types 
provide highly functional tissue constructs that may be used for therapeutic or 
investigational applications. The hepatic function modulations due to cell-cell 
interactions in hepatic co-cultures may be due to homotypic hepatocyte interactions or the 
effects of hepatocytes on each other, the heterotypic interactions or the amount of contact 
between cell populations and the homotypic interactions of the non-hepatocyte 
population, which may produce secondary effects on hepatocellular response [23]. 
Hepatocytes were briefly discussed in Section 1.2.  They preform most of the functions of 
the liver and work together with a number of other cell types to perform the various 
functions essential for the survival of the individual. The non-parenchymal cells of the 
liver are sinusoidal endothelial cells, Kupffer cells and stellate cells. Co-culture of 
primary rat hepatocytes with other cell types can maintain liver-specific functions for 
several weeks in vitro [5]. The first successful hepatocyte co-culture system was reported 
by Guillouzo et al, when adult rat hepatocytes were cultured with rat liver epithelial cells, 
it exhibited higher and stable secretion of albumin for longer periods of time compared to 
pure cultures of hepatocytes[16, 24]. Table 1.3 lists the various cell sources used for co-
culture with rat hepatocytes for long term hepatic function. Similar results have been 
found with human, chick, porcine and fetal rat hepatocytes[25].  
 
12 
 
Table 1.3:  List of Cell Types used in Co-culture with Rat Hepatocytes for Long 
Term Hepatic Function [25] 
Liver derived Cells Non-liver derived Cells 
Rat Liver epithelial (presumed biliary 
origin) 
Stellate 
Sinusoidal endothelial 
Kupffer  
‘Non-parenchymal” fraction of isolated 
population 
Bovine aortic endothelia 
Canin kidney epithelia 
Chinese hamster pithelia 
Embryonic murine (3T3, C3H, 10T
 
 
) 
Human fibroblast 
Human lung epithelia 
Human venous endothelia 
Monkey kidney epithelia 
Rat dermal fibroblast 
 
The co-culture system has also been found to retain  total CYP P450 content, 
triglyceride and urea synthesis, phase I and II biotransformation reactions, normal bile 
acid transport properties and the ability to secrete α2–macroglobulin after stimulation by 
cytokines and enhance gap junctional intercellular communications [1, 26].  
The higher viability and maintenance of function of hepatocytes co-cultured with 
other cell types requires intercellular contact or otherwise known as the heterotypic cell-
cell interactions [27, 28].  The hepatocyte morphology and functions vary according to 
the co-culture cell type. In vivo hepatocytes are large, compact polyhedral cells with a 
round nuclei and prominent nucleoli but when isolated and culture alone, they lose their 
function and also many of their characteristic features. The cell borders become indistinct 
and the actin cytoskeleton undergoes rearrangements leading to a ‘fibroblast-like’ 
appearance, which eventually leads to necrosis and cell death. However, when 
hepatocytes are grown in co-cultures, it exhibits stereotypical polygonal morphology with 
distinct nuclei and nucleoli, distinct cell-cell borders and a visible bile canalicular 
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network for many weeks [7, 25, 29].  The differences in morphologies and function with 
different co-cultures may be due to the different proliferative responses of hepatocytes in 
the various co-cultures. It may also be due to variations in cell signaling, growth factor 
release, ECM deposition and protein production[21]. 
1.9 Tissue Engineering 
Liver tissue engineering research has focused mainly on transplanting hepatocytes and 
the liver parenchymal cells which perform the liver functions and make up 80% of the 
cytoplasmic mass [30]. Implantable tissue engineered liver devices mainly aim to provide 
long term hepatic support, which is congruent to the objective of this research. Hence, 
exploring the potential of tissue engineering in the development of the 3-D model is 
necessary.   
The main principle of tissue engineering is the ideal interaction between the cells 
and a three dimensional cellular matrix. An ideal scaffold must sustain the biological 
process of the cells, including cell attachment, migration, and differentiation and self-
assembly of groups of cells. It must also have the physical and chemical properties that 
will support the purpose of utilization. The success of tissue engineering depends upon 
the ability to provide a microenvironment that supports the viability of hepatocytes which 
maintain liver-specific functions. Many scaffolds have been developed in the past years 
for the culture of hepatocytes in vitro with the ultimate goal of maintaining the 
functionality and viability of large mass of isolated hepatocytes. 
Cell-ECM plays an important role in regulating cellular process such as cell 
proliferation, migration, differentiation and survival. The control of physicochemical 
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properties of ECM makes it easier to optimize the functional maintenance of the cells in 
vitro [31]. 
Liver tissue engineering research has explored the utilization of different types of 
materials and structure to develop a viable tissue construct such as microcarriers and 
encapsulation techniques. However, the most successful model is a polymer scaffold 
which provides a place for attachment, increased surface area, support for a larger cell 
mass and the capability of shaping specific structures [5]. High metabolic functions of the 
hepatocytes require a polymer scaffold with at least 95% porosity to allow vascular 
ingrowth, exchange of nutrients and wastes. Scaffolds with large surface to volume ratios 
have shown to promote hepatocyte attachments[30]. 
1.10 Chitosan 
Chitosan is derived from chitin, which occurs in nature as ordered microfibrils in 
exoskeleton of arthropods, cell wall of microorganisms and fungi. Chitin is a 
mucopolysaccharide consisting of a 2-acetamido-2deoxy-β-D-glucose through a β 1,4 
configuration[32]. Chitosan is formed when chitin undergoes partial deacetylation. 
Chitosan is a linear polysaccharide, composed of randomly placed N-acetyl-glucosamine 
and N-glucosamine units on a polymer chain in the β -1,4-configuration. The chemical 
structure of chitin and chitosan are shown in Figure 1.4.  
Chitosan is generally characterized by its molecular weight and degree of 
acetylation (which is the percentage measurement of free amine groups along the 
chitosan backbone) [33]. It is insoluble in neutral and alkaline solutions. Chitosan is 
soluble in inorganic and organic acids such as glutamic acid, hydrochloric acid, lactic 
acid and acetic acid. The protonation of chitosan changes it into a polyelectrolyte in 
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acidic solutions [25]. The viscosity of chitosan solution increases with increase in 
chitosan concentration and decrease in temperature. It also increases with increasing 
degree of deacetylation. The differences in properties due to degree of acetylation are due 
to the differences in conformation of the molecule for high and low deacetylated chitosan 
[34].  
 
Figure 1.4  Structure of chitin and chitosan [28, 33, 35]. 
 
Chitosan is biocompatible, biodegradable, biologically renewable, non-antigenic, 
non-toxic and  is an anti-microbial and hydrating agent [32, 33, 36]. It is also easily 
processed into gels, membranes, nanofibers, beads, nanoparticles, scaffolds and sponges. 
Chitosan is an ideal scaffold material for hepatocyte culture due to its structure, 
similar to glycosaminoglycans, the components of liver ECM. It is extremely important 
to mimic the in vivo environment as hepatocytes are anchorage-dependent cells and 
highly sensitive to biochemical property of the ECM [37]. 
 
1.11 Fibronectin 
Hepatocyte growth and function are affected by the microenvironment i.e. ECM, thus it is 
critical to develop an appropriate scaffold for liver tissue engineering. The nature of the 
Chitin Chitosan 
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ECM cultured with the hepatocytes influence cellular interactions which in turn can 
determine both cell shape and cytoarchitecture [38]. A wide number of glycoproteins 
have been found to mediate cell spreading and attachment namely, collagen, epibolin, 
fibronectin, serum spreading factor, laminin and chondronectin [39]. For hepatocytes, the 
effect of collagen, laminin and fibronectin on cell spreading properties have been studied. 
It has been found that fibronectin enhanced hepatocyte spreading and flattening more 
than type I or type IV collagen and even more compared to laminin [40]. 
Fibronectin is a large glycoprotein of approximately 2,300 amino acids and 5% 
carbohydrates. It is made up of three homologous peptide sequences. Type I and Type II 
sequences are composed of disulfide loops of 45 and 60 amino acids, respectively. Type 
III homology sequence consists of about 90 amino acids and some of the sequences 
contain a free sulfhydryl groups. The sequences are arranged in a linear array to form two 
nearly identical subunit arms as shown in Figure 1.5 [41, 42]. 
 
 
 
 
 
 
 
 
 
Figure 1.5:  Structure of fibronectin [41]. 
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 It exists in the blood as a dimer and found in tissues as an insoluble fibrillar 
matrix. Studies have shown that the dimer and fibrillar matrix forms of fibronectin 
interact differently with cells. The latter form is the most common form for cellular 
interactions [43]. 
1.12 Electrospinning 
Hepatocytes are anchorage dependent cells and thus, interaction with the ECM influences 
aggregation. Most cells in in vivo adhere to the ECM which has an extremely complex 
topography in the nanometer range. In order to mimic this topography, many materials 
have been fabricated into nanomaterials and have been found to affect cell migration, 
adhesion, proliferation and other cellular behaviors [44]. Cell-substrate interactions are a 
major factor in formation of aggregates. Studies have shown that by increasing  the cell-
substrate adhesion strength by utilizing nanofibers increases the available contact area 
between individual cells and the substrate [45]. Cells have been found to adopt more in 
vivo like morphologies when cultured on 3-D scaffolds as compared to 2-D. A 3-D 
culture drastically changes the mechanical signals in ECM affecting cell-receptor 
ligation, intercellular signaling and cellular migration. It also influences the diffusion and 
adhesion of proteins, growth factors and enzymes which ensures cell viability and 
function [46]. Chitosan nanofibers scaffolds have been found to mimic the in vivo 
microenvironment of the hepatocytes and promote hepatocyte-scaffold interactions which 
lead to better viability and hepatic function. Cytochrome P450 activity, urea synthesis 
and albumin secretion was found to be 1.5 to 2 times higher [44].  
Electrospinning is a technique which provides a versatile and rapid method to 
fabricate nanofibrous scaffolds in the small scale. It has been gaining popularity in 
18 
 
industrial applications as it fabricates various materials such as synthetic and natural 
polymers, ceramics, metals and composites in the nanometer range with low cost and 
high yielding [47].  Electrospun scaffolds are generally non-woven fibers with inherent 
high porosities, high surface area-to-volume ratio and offers a wide variety of 
topographical features [46, 48, 49].  
The electrospinning apparatus follows the principles of electrostatic forces to 
stretch the solution. A basic apparatus consists of three main components: a high voltage 
power supply, a syringe with a metal spinneret of small diameters and a grounded 
collecting plate (metal screen, plate or rotating mandrel). A charged polymer solution is 
taken in the syringe and fed through the spinneret under an external electric field. A 
suspended conical droplet is formed when the surface tension of the droplets is in 
equilibrium with the electric field. As the applied electric field is increase, the cone 
shaped droplet stretches until it overcomes the surface tension. At this point, an 
electrified liquid jet of the polymer solution is electrostatically driven towards the 
collector. The fluid jet solidifies into a nanofiber through evaporation of the solvent. This 
results in the deposition of the non-woven fibrous scaffold on the collector. The fiber 
thickness and morphology can be controlled by various factors such as the properties of 
the polymer solution, electric field strength, the electrospinning distance, temperature and 
humidity [18, 47, 49, 50]. 
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CHAPTER 2    
MATERIALS AND METHODS 
2.1 Cell Cultures 
2.1.1 Fibroblast Cultures 
3T3-J2 fibroblasts (Fb; purchased from Howard Green, Harvard University) were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) High Glucose, 10% Fetal 
Bovine Serum (FBS) and 2% Penicillin/Streptomycin (P/S) at 37°C and 10% CO2. The 
medium was changes every 2-3 days. 
2.1.2 Human Hepatocellular Liver Carcinoma Cell Line Cultures 
The tissue culture dish was first coated with 0.1% gelatin at room temperature for 30 – 60 
minutes. Once, the gelatin has been aspirated the human hepatocellular liver carcinoma 
cell line (HepG2; gift from Dr. Charles Ross, Rutgers University) cells were seeded and 
cultured in DMEM High Glucose, 10% FBS, 2% P/S and 1% L-glutamine at 37°C and 
10% CO2. The medium was changed every 2-3 days. 
2.1.3 Liver Sinusoidal Endothelial Cell Cultures 
Liver Sinusoidal Endothelial Cells (LSEC) medium consists of DMEM High Glucose, 
10% FBS, 2% P/S, 10 ng/ml Vascular Endothelial Growth Factor (VEGF), 1% L-
glutamine, 1% Insulin-Transferrin-Selenium (ITS) solution. Cryopreserved rat LSECs 
were used in this study. The cells were cultured at 37°C and 10% CO2. The medium was 
changed every 2-3 days. 
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2.1.4 Adult Primary Rat Hepatocyte Cultures 
Adult primary rat hepatocytes (AH) medium consisted of DMEM High Glucose 
supplemented with 10% FBS, 2% P/S, 7ng/ml glucagon, 7.5 µg/ml hydrocortisone, 
0.5U/ml insulin and 20ng/ml endothelial growth factor (EGF). The cells were cultured at 
37°C and 10% CO2. Cryopreserved adult hepatocytes isolated from rat liver (provided by 
Dr. Arno Tilles, Harvard Medical School) were used in this study. These cells cultured 
alone were used as the monocultures for comparison with co-culture models. The 
medium was changed daily and medium samples were collected for future functional 
analysis. 
2.1.5 Hepatocyte-Fibroblast Co-cultures 
Fibroblasts were maintained in P60 tissue culture dishes in fibroblast medium previously 
described in Section 2.2.1. After reaching confluence, the fibroblasts were washed with 
phosphate buffer solution (PBS), trypsinized and plated into culture dishes in AH 
medium prior to seeding hepatocytes. AH cells were trypsinized and seeded into the 
previously prepared culture dishes with a cell seeding ratio of 1:1. The cell seeding 
density was typically 0.5 × 10
5
 cells for a 12 well plate. Culture medium utilized for the 
co-cultures was AH medium and it was changed daily. Medium samples were collected 
for future functional analysis.  
2.2 Preparation of 1% Gelatin 
For the preparation of 1% gelatin, 0.5g of gelatin powder was dissolved in 49.5ml of 
autoclaved distilled water at 50°C. The solution is filtered using a vacuum filter and the 
solution is stored in 20°C for later use. 
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2.3 Preparation of 1% Chitosan 
For the preparation of 1% chitosan, 0.5g of chitosan powder was mixed with 49.5ml of 
distilled H2O.  The homogeneous chitosan solution was either used immediately or was 
stored in 20°C for later use.  
2.4 Preparation of 2-D Chitosan - Fibronectin Scaffold 
Tissue culture dishes (24-well) were coated with 300μL of 1% chitosan solution for 
overnight incubation at room temperature. 0.2M NH4OH was added to each well plate to 
neutralize the chitosan coating for 5 min at room temperature in the sterilized culture 
hood. The dishes were than washed with sterile deionized water (dH2O) twice for 10 
minutes each. Sterile fibronectin (10µg/ml) was added to the plates and incubated for at 
least an hour. The fibronectin was aspirated and the cells were seeded. 
2.5 Preparation of 3-D Chitosan Nanofibers via Electrospinning 
0.8g of medium molecular weight chitosan (75% deacetylated) was dissolved in 
Trifluoroacetic acid (TFA) to prepare 8% (w/v) chitosan solution in the fume hood and it 
was stirred at 60°C for 12-15 hours. Afterwards, 2mL of methylene chloride was added to 
the polymer solution and stirred well for 5 minutes at 40°C. TFA is used as the solvent as 
it degrades the chitosan chains in order to lessen the viscosity and methylene chloride 
was added in order to prevent bead formation. The stock solution was then filled into a 10 
ml plastic syringe fitted with an 18 gauge needle and then pushed out at 2 – 6ml/h using 
the syringe pump. A DC voltage of 20-25kV was applied between the syringe tip and a 
22 
 
square metal collector. The typical distance between the syringe tip and the grounded 
collector was about 12-15cm. 
Figure 2.1   Schematic representation of the electrospinning apparatus. 
2.6 Preparation of 3-D Chitosan-Fibronectin Scaffold 
In order to prepare the three dimensional chitosan-fibronectin scaffold for cell seeding, 
the chitosan mats were cut into circular shapes of area 3.8 cm
2
 and placed on each plate 
individually. A mixture of NH4OH:C2H5OH (1:1) was added to each well plate to 
neutralize the mats for 30 mins at room temperature in the sterilized culture hood. The 
mates were than washed with sterile dH2O twice for 10 minutes each. Sterile fibronectin 
(10µg/ml) was added to the plates and the mats were allowed to soak for at least an hour 
for the glycoprotein to be adsorbed on the surface. The fibronectin was aspirated and 
culture media was added to flatten out mats and remove media. 
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2.7 Immunofluorescence Staining 
For immunofluorescence staining, the cells cultured were fixed with 4% 
paraformaldehyde for 10 min at room temperature in their respective culture dishes.  The 
fixed tissues were washed twice with a solution mixture of 1X PBS. In order to 
permeabilize the cells, 0.2% Triton X-100 was added for 10 min at room temperature. 
The cells were then washed with 1X PBS twice. In order to block non-specific binding 
sites the cells were incubated with blocking solution (10% FBS and 1% bovine serum 
albumin (BSA) in PBS) for 30 – 60 minutes at 37ºC. Excess blocking solution was 
drained off and the cells were incubated with primary antibodies: mouse anti-vinculin 
(1:200) for vinculin staining and rabbit anti-rat albumin (1:200) for albumin staining for 
at least 1hour at room temperature in blocking buffer. Then, the cells were washed thrice 
with 1X PBS for 5 min each time. Next, it was incubated with the secondary antibody, 
anti-mouse IgG Alexa Fluor 488 for vinculin (1:500) and anti-rabbit IgG Alexa Fluor 594 
(1:500) at room temperature for 1 h in blocking solution. Actin phalloidin (1μl/ml) was 
added at this point for 1 h incubation at room temperature for actin cytoskeleton staining. 
The dishes were washed thrice again with 1X PBS for 5 min each time. DAPI (1μl/ml) 
was added and incubated for about 3 minutes for nuclear staining. The cells were than 
washed with 1X PBS. The cells were then viewed under the fluorescence microscope. 
2.8 Safranin-O Staining 
The fixed 3-D culture was incubated with 1ml of Safranin-O dye solution (Sigma) for 1 
min and then washed with deionized H2O three times. The stained cells were views under 
the microscope. 
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2.9 Albumin Assay 
The culture medium samples were collected on Days 4, 8, 12, 18 and 22. The samples 
were stored at –20°C for further analysis. The wells of a 96-well plate were incubated 
with albumin (5mg/ml) in PBS overnight at 4°C. The plate was washed four times with 
100μl of PBS-Tween. Standard solutions in culture medium were prepared for 100, 50, 
25, 12.5, 6.25, 3.125, 1.0625 and 0μg/ml. 50μl of standard solution and the samples were 
added to each well followed by the addition of Peroxidase conjugated sheep IgG anti-rat 
albumin (1:5000) in PBS-Tween and incubated overnight at 4°C. The plate was 
repeatedly washed four times with PBS-Tween. Substrate buffer consisting of 0.2M 
sodium phosphate and 0.1 M citric acid was prepared and 10mg of o-phenylenediamine 
dihydrochloride (OPD) was dissolved in 25ml of the buffer solution at room temperature. 
10μl of 30% hydrogen peroxide was added to the solution. The columns containing the 
samples were filled with 100μl/well of the prepared solution at regular time intervals 
(approx. 10 seconds). The columns were then treated with 50μl/well of 8N of sulfuric 
acid was added 5 mins after the initial start time. The absorbance was measure with a 
microplate reader at a wavelength of 450nm or 490nm.  
2.10 Ethoxyresorufin-O-dethylase Assay 
Cytochrome P-450 A1 (CYPA1) enzymatic assay was assessed by measuring the 
ethoxyresorufin-O-dethylase (EROD) activity. The cultures were induced to produce 
CYPA1 by 2μM of 3MC for 48 hours before measuring the EROD activity on Day 14 
and Day 29. The cells were then washed well with PBS followed by  1 hour incubation 
with 8 μM ethoxyresorufin phenol free culture medium at 37°C. The medium is collected 
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after incubation and the fluorescence intensity is measured. Resorufin was detected in the 
samples at an excitation wavelength of 530nm and emission wavelength of 590nm 
against resorufin standards using the fluorometer.  
2.11 Image Analysis 
Image analysis was conducted with the help of SigmaScan Pro 5 software. To determine 
the effect of fibronectin on cell spreading properties the average area and shape factor of 
AH, Fb, HepG2 and LSEC were analyzed. The average diameter of the chitosan 
nanofibers were also calculated with the help of the software 
2.12 Scanning Electron Microscope 
The 3-D co-culture model was gently washed with PBS three times and fixed with 2% 
glutaraldehyde in PBS and kept at 4°C overnight. The culture was then washed twice 
with PBS and incubated with 70% ethanol for 5 minutes. The solution is removed and the 
culture is then incubated with 95% ethanol for 5 minutes. The solution is removed and 
the cultured sample was placed in a dessicator for vacuum drying overnight. The samples 
were than coated with copper before viewing under the scanning electron microscope 
(SEM). 
2.13 Statistical Analysis 
Experiments were repeated at least 3 times with triplicate samples for each condition. 
Data are expressed as the mean ± standard deviation. Statistical significance was 
determined by a two – tailed Student’s t-test (*P<0.05). 
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CHAPTER 3    
RESULTS AND DISCUSSION 
3.1  Fabrication and Characterization of Chitosan Nanofiber 
For 3-D cultures, pure chitosan nanofibers were fabricated with an average diameter of 
approximately 83.2 ± 17.2 nm, through electrospinning as shown in Figure 3.1. 
Electrospinning is a simple and cost-effective technique to fabricate nanofibers. The 
electrospun fibers obtained were non-woven with high porosity, structural integrity and 
surface area. Nanofibers are used extensively in tissue engineering to mimic the natural 
ECM and to provide a three dimensional structure for the cells to grow as previously 
described in Chapter 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1  SEM images of the electrospun chitosan nanofibers. 
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3.2 Optimization of Scaffold Microenvironment 
 
Hepatocytes are very sensitive due to their anchorage dependent nature. Hence, their 
morphologies and function are heavily influenced by their microenvironment. Therefore, 
it is necessary to optimize the microenvironment specifically for hepatocyte cultures. 
Thus, the effect of fibronectin on cell morphologies on different cell types namely, 
fibroblasts, LSEC, HepG2 and AH was observed. The cells were cultured on chitosan and 
chitosan-fibronectin films, which were later fixed on Day 2 for immunostaining analysis. 
Cell morphology and behavior on the different substrates were evaluated by F-
actin, Vinculin and DAPI staining. Figure 3.2 shows phase contrast, F-actin, Vinculin and 
DAPI stained images of fibroblasts, LSEC, HepG2 and AH cultured on chitosan and 
chitosan-fibronectin on Day 2. The cells that were cultured on chitosan films maintained 
a round and circular morphologies, while cells grown on chitosan-fibronectin films 
exhibited elongated, polygonal shapes which indicated better cell adhesion. 
 In order to quantify cell spreading and shape factors, the data was normalized to 
analyze the effect of fibronectin on morphologic characteristics of the different cell types.  
All the cells cultured on different substrates were evaluated for projected spreading area 
and shape factor as shown in Figure 3.3a and 3.3b, respectively. Cells which adopted 
flattened, polygonal shapes were considered to have better attachment and adhesion 
properties as compared to cells with round morphologies. Figure 3.3a shows clearly that 
the cells grown on chitosan-fibronectin films have higher spreading as indicated by the 
larger area occupied by cells relative to chitosan films. A shape factor is equal to one for 
a perfect circle and a value of zero for elongated shapes. Figure 3.3b shows that cells that 
were cultured only on chitosan have values close to one as compared to cells that were 
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grown on chitosan-fibronectin films, which had values closer to zero in all cases. This 
indicated that fibronectin further enhances cell adhesion and spreading. 
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Figure 3.2  Morphological Characterisitcs of Different Cell Types - Day 2 images of different cell types namely – (i) Fibroblasts, (ii) 
LSEC: Liver Sinusoidal Endothilial Cells, (ii) HepG2: Human hepatocellular liver carcinoma cell line, (iii) AH: Adult  Hepatocytes; 
on Chitosan (CS) and Chitosan-Fibronectin (CS-FN) film.            
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Figure 3.2 (Continued)  Morphological Characterisitcs of Different Cell Types - Day 2 images of different cell types namely – (i) 
Fibroblasts, (ii) LSEC: Liver Sinusoidal Endothilial Cells, (ii) HepG2: Human hepatocellular liver carcinoma cell line, (iii) AH: Adult 
Hepatocytes; on Chitosan (CS) and Chitosan-Fibronectin (CS-FN) film.
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Figure 3.3a  Effect of fibronectin on adhesion properties of different cell types - The 
average of area of cells on Day 2 were analyzed to find the effect of fibronectin on cell 
spreading and adhesion. Student t-test indicated there was significant differences (*P < 
0.05) between chitosan film and chitosan-fibronectin film cultured cells. 
 
 
Figure 3.3b  Effect of fibronectin on shape factor for different cell types - The shape 
factor for each cell on Day 2 were determined to analyze the effect of fibronectin on cell 
spreading and adhesion. Student t-test indicated there was significant differences P < 
0.05) between chitosan film and chitosan-fibronectin film cultured cells.  
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3.3 Characterization of Liver Model 
 
The liver model fabricated was characterized by observing cell morphology, behaviour 
and functions. Cell morphology of mono-culture and co-culture on 2-D fibronectin coated 
scaffolds were studied on Day 6, 18 and 24, as shown in Figure 3.4. On Day 6, 
hepatocyte mono-cultures showed distinct polygonal morphologies with good cell 
spreading properties. As the days progressed, the cells were found to lose their structure 
and die as early as in the second week of culture. In contrast, co-cultures on Day 6, show 
a mixed cell population of fibroblasts and adult hepatocytes without any distinct 
morphological differences. By Day 18, the hepatocytes are found to have formed distinct 
colonies indicated by the polygonal morphology, canicular bile tracts and the presence of 
binucleolous, characteristic of hepatocyte cells. This cell morphology is still maintained 
on Day 26, which indicates that the system may be used for prolonged long term cultures.  
Safranin-O stained images of co-cultured cells on 3-D fibronectin coated 
nanofibers on Day 14 were obtained as shown in Figure 3.5a. Safranin-O stains red and 
from the image it is clearly seen that the nanofibers promote the growth and proliferation 
of hepatocytes and fibroblasts in co-cultures. 
SEM images of co-cultures cells on 3-D fibronectin coated scaffolds (nanofibers) 
on Day 14 were observed, as shown in Figure 3.5b. It can be seen that the fibroblasts and 
hepatocytes interact and integrate well with the nanofiberous network. The fibroblast 
cells hav also shown to have formed bridges between nanofibers, in addition to its 
proliferation. The hepatocyte colonies and the fibroblasts are also shown to interact in the 
SEM images. 
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Production of albumin is one of the main synthetic functions of hepatocytes, as it 
constititues upto 25% of total proteins synthesized in the liver. The co-cultures in both 2-
D and 3-D were stained for albumin on Day 14 and images were obtained as shown in 
Figure 3.6. The DAPI image shows a large number of cells however, only the 
hepatocytes colonies are stained in red, indicating albumin secretion. Thus, it 
differentiates the hepatocyte colonies from fibroblasts in the co-cultures. 
Albumin secretion on Day 4, 8, 12, 18 and 22 are shown in Figure 3.7a and b. The 
production of albumin for monocultures reached a peak on Day 4 and then slowly 
decreased in both 2-D and 3-D cultures. However, in the case of co-cultures, it was 
shown that there is gradually increase in albumin secretion as the days progressed. 
Student t-test indicates that there is no statstical significance between the albumin 
concentration on Day 4 and Day 8 between monocultures and co-cultures in 2-D 
scaffolds. 
A 3-D culutre reduces the gap between cell culture and in vivo tissue by providing 
a microenvironment similair to that found in real tissues. The microenvironment mimics 
the geometry, mechanical properties and the biochemical aspects of the real tissue. This 
helps establish cell-cell and cell-substrate interactions similar to that found in the natural 
physiological environment.  Thus, original morphologies and liver-specific function is 
maintained as indicated by the results. The inherent complexity of co-cultures makes it 
diffcult for the characterization of cell-cell interaction and its effect on function. Thus, it 
is still unclear as to the specific mechanisms of co-cultivations lead to better tissue 
funciton. 
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Figure 3.4  Morphological characteristics of hepatocytes in monoculture and co-culture - Phase contrast images of hepatocytes 
cultured alone and co-cultured with fibroblasts on fibronectin coated surfaces on Day 6, Day 18 and Day 26. Scale bar: 100μm.
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Figure 3.5a  Morphological characteristics of hepatocytes and fibroblast in 3-D co-culture – Safranin-O stained images of co-cultured 
3-D liver model for Day 14. Scale bar: 1000 μm, 100 μm. 
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Figure 3.5b Morphological characteristics of hepatocytes and fibroblast in 3-D co-culture - SEM images of co-cultured 3-D liver 
model for Day 14. 
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Figure 3.6  Albumin stained images of co-cultures in 3-D culture systems on Day 14. Scale bar: 50 μm.  
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Figure 3.7a  Albumin secretion in short term culture – Albumin secretion in (i) monoculture of primary rat hepatocyte (ii) co-culture 
of primary rat hepatocytes and fibroblasts cultured on fibronectin coated dish on Day 4, Day 8 and Day 12. Each data point showed is 
the mean (n =6). A student t-test was conducted and the calculated P-values are shown.  
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Figure 3.7b  Albumin secretion in long term culture – Albumin secretion of (i) monoculture of primary rat hepatocyte (ii) co-culture 
of primary rat hepatocytes and fibroblasts cultured on fibronectin coated - chitosan nanofibers on Day 18 and Day 22. Each data point 
showed is the mean (n =6). A student t-test showed that p < 0.05 for all cases, which indicates statistical difference. 
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3.4 Utilization of 3-D Liver Model for Drug Screening Applications 
 
CYP 450 enzymes family are essential for detoxification and metabolism of drugs in the 
body. There are about 50 enzymes altogther out of which 5 are responsilbe for 90% of 
drug metabolism.  EROD assay was conducted to determine the CYP450  1A enzyme 
induction by the hepatocyte cells cultured in monoculture and co-culture.  
Dealkylation of 7-ethoxyresorufin by adult rat heaptocytes are shown in Figure 
3.8. In monoculture the formation of resorufin by Day 14 is maredly low compared to 
that found in co-cultures in both 2-D and 3-D cultures. CYP450 A1 induction was also 
markedly elevated in co-cultured cells on nanofibers in long term (day 29) cultures. The 
values are expressed as means ± standard deviations. 
High levels of cytochrome in 2-D cultures may be attriubuted to the large 
interindividual variations that exist between indvidual cytochrome P450 enzymes due to 
phenotypic differences of fenetic polymorphoisms. Cells in 2-D prevalently proliferate 
and de-diffrentiate, which leads to morphological and functional differences from that of 
original tissues. The 3-D culture system is closer to the environment found in in vivo and 
thus, it may be assumed that the cytochrome levels observed here, may be closer to that 
found in nature. 
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 Figure 3.8  Comparison of CYP450 activity for short term and long term culture -  Comparison of the induction of EROD activity by 
3-methylcholanthrene in primary rat hepatocyte in 3D nanofiber and 2D culture on Day 14 and Day 29. It showed significant 
differences in CYP450 activity. Student t- test showed that  P<0.05, which indicates a significant statistical difference.
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CHAPTER 4        
CONCLUSION 
4.1 Summary   
It is extremely time consuming and expensive to introduce a new drug into the market. 
The total cost from research to market has been found to range between 0.8 to 1.1 billion 
US dollars. It is necessary to develop a pre-clinical assay that fastens and make it easier 
to select the promising drug candidates.  
A 3-D liver model was developed with pure chitosan nanofibers and co-culture 
system consisting of fibroblasts and hepatocytes. The nanofibers were fabricated by the 
novel method of electrospinning. The chitosan nanofibers were highly porous and 
randomly oriented with an average diameter of 83.171 ± 17.207 nm. The study of the 
effect of fibronectin on different types of cells – Fb, LSEC, HepG2 and AH, showed that 
the glycoprotein enhances cellular adhesion in fibroblasts, endothelial, liver and liver-like 
cells. Comparison of hepatocyte monocultures and hepatocyte-fibroblast co-cultures in 
different dimensions indicated that the hepatocytes in co-cultures formed colonies which 
maintained morphologies and functions for prolonged period of time. The drug 
metabolism of liver is controlled mainly by its ability to produce cytochrome P450 
enzymes and EROD activity showed that the developed model produced adequate 
amounts of CYP450 A1 enzyme.  The 3-D model developed in this study will provide 
useful tools towards the development of engineered liver tissues for drug screening and 
tissue engineering applications.  
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4.2 Future Considerations 
In the present study, a novel approach was introduced to develop an in vitro three 
dimensional model of liver utilizing nanofibers and co-culture systems. However, further 
investigation with regard to its application for drug screening is required. An acute and 
chronic exposure test should be conducted on the model in order to further support drug 
screening applications. Although cells cultured on the scaffolds expressed good results 
for the functional assays conducted. A urea study could be used to further analyze hepatic 
function of the liver model and Phase II drug metabolism activities. The functional and 
metabolic activities of the model maybe compared to natural liver and currently available 
in vitro drug screening tests. 
In vivo application of the liver model should also be explored in further studies as 
the model overcomes the limitations of short term hepatocytes cultures found in liver 
tissue engineering for implantation purposes and for bioartificial liver (BAL) devices. 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
APPENIDIX 
ECM Extracellular matrix 
CYP450 Cytochrome P450  
ADME Absorption, distribution, metabolism and excretion 
DDI Drug-drug interactions 
Fb Fibroblasts 
HepG2 Human hepatocellular liver carcinoma cell line 
LSEC Liver sinusoidal endothelial cells 
AH Adult rat hepatocytes 
DMEM Dulbecco’s modified eagle medium 
FBS Fetal bovine serum 
P/S Penicillin/Streptomycin 
VEGF Vascular endothelial growth factors 
ITS Insulin-Transferrin-Selenium 
PBS Phosphate buffer solution 
EGF Endothelial growth factor 
TFA Trifluoroacetic acid 
dH2O Deionized water 
BSA Bovine serum albumin 
EROD Ethoxyresorufin-O-dethylase 
CYP40 A1 Cytochrome P450 Type A1 
SEM Scanning electron microscope 
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